Letters to the Editor
Additional Screenings in the Adult Well Male Examination
FREE PREVIEW Log in or buy this issue to read the full article. AAFP members and paid subscribers get free access to all articles. Subscribe now.
FREE PREVIEW Subscribe or buy this issue. AAFP members and paid subscribers get free access to all articles.
Am Fam Physician. 2012 Oct 1;86(7):594.
Original Article: The Adult Well Male Examination
Issue Date: May 15, 2012
Available at: http://www.aafp.org/afp/2012/0515/p964.html
to the editor: This review of the adult well male examination discussed the prevention of cardiovascular disease, but did not mention screening of the heart itself. Shouldn’t family physicians be looking for occult or asymptomatic conditions, such as ventricular hypertrophy, ischemic disease, valvular malformations, dysrhythmias, and prolonged QT interval? Please provide guidance about which populations should be screened with electrocardiography, chest radiography, echocardiography, or other studies to detect cardiovascular diseases before they become symptomatic.
Similarly, there was no discussion of the importance of vision examinations in older men to diagnose conditions such as glaucoma, cataracts, macular degeneration, and corneal dystrophy, which would require referral to an ophthalmologist.
in reply: The U.S. Preventive Services Task Force (USPSTF) found insufficient evidence to support screening for ventricular hypertrophy and ischemic heart disease using electrocardiography1 or nontraditional risk factors such as coronary artery calcification score.2 Neither the USPSTF guidelines nor any other evidence-based guideline suggests screening for valvular disease, dysrhythmias, and prolongation of the QT interval in asymptomatic patients.
The American Heart Association estimates the theoretical cost of mass cardiovascular screening in athletes to be $2 billion per year, with a cost of $330,000 to detect a single case of relevant cardiac disease.3 If one in 10 athletes with asymptomatic cardiac disease is at increased risk for sudden death without treatment, then the cost of preventing each theoretical death would be $3.4 million.3
Regarding whether to routinely screen older men for glaucoma, cataracts, macular degeneration, and corneal dystrophy, the USPSTF states that current evidence is insufficient to assess the balance of benefits and harms of screening for visual impairment in older adults.4 Based on expert consensus, the American Academy of Ophthalmology recommends a comprehensive medical eye examination for all asymptomatic adults without risk factors for medical eye disease; screening should occur every five to 10 years in patients younger than 40 years, every two to four years in those 40 to 54 years of age, every one to three years in those 55 to 64 years of age, and every one to two years in those 65 years and older.5
1. Chou R, Arora B, Dana T, Fu R, et al. Screening asymptomatic adults with resting or exercise electrocardiography: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2011;155(6):375–385.
2. U. S. Preventive Services Task Force. Using nontraditional risk factors in coronary heart disease assessment: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;151(7):474–482.
3. Maron BJ, Thompson PD, Ackerman MJ, et al. Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update. Circulation. 2007;115(12):1643–1655.
4. U.S. Preventive Services Task Force. Screening for impaired visual acuity in older adults. http://www.uspreventiveservicestaskforce.org/uspstf/uspsviseld.htm. Accessed July 6, 2012.
5. American Academy of Ophthalmology. Comprehensive adult medical eye evaluation. http://guideline.gov/content.aspxid=25644&search=vision+and+vision+screening. Accessed July 6, 2012.
Send letters to Kenneth W. Lin, MD, MPH, Associate Deputy Editor for AFP Online, e-mail: firstname.lastname@example.org, or 11400 Tomahawk Creek Pkwy., Leawood, KS 66211-2680.
Please include your complete address, e-mail address, and telephone number. Letters should be fewer than 400 words and limited to six references, one table or figure, and three authors.
Letters submitted for publication in AFP must not be submitted to any other publication. Possible conflicts of interest must be disclosed at time of submission. Submission of a letter will be construed as granting the American Academy of Family Physicians permission to publish the letter in any of its publications in any form. The editors may edit letters to meet style and space requirements.
Copyright © 2012 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact email@example.com for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions